Caring for the Critically Ill Patient with COVID-19

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

“…Although, COVID-19 therapy was not explicitly investigated in our cohort, the early initiation of corticosteroids so as the introduction of tocilizumab and antibodies in the management of severe COVID-19, may have potentially improved the outcome of these patients. The justified fear of further immunodepression using targeted therapeutic approaches lessened over time that early initiation of such therapies may also be beneficial in patients with haematological malignancy [ 9 , 34 ].…”